Valuation

OMCLOmnicell Inc

StockNasdaqAmerika Birleşik DevletleriHealth careEU retail: available

6/10

Ratios vs sector

Medians of Health care companies in the same region (stocks and REITs).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.
Metric	OMCL	Sector median	vs median
P/E	41,3	28,8 · n=114	%43 above
P/B	1,2	3,0 · n=196	%59 below
P/S	1,3	3,7 · n=202	%65 below
EV/EBIT	25,7	24,1 · n=103	%7 above
Free-cash-flow yield	%8,8	%2,8 · n=187	%215 above
Dividend yield	%0,00	%0,00 · n=215	—
Return on equity	%3,1	%2,7 · n=193	%15 above
Return on invested capital	%3,2	%3,5 · n=176	%11 below
Gross margin	%44,8	%62,5 · n=152	%28 below
Net debt / EBITDA	−0,92	1,19 · n=108	%177 below

Value factor: 91 of 100 within the peer group. Full score breakdown →

Sector peers

The largest companies of the same sector and region.

Instrument	P/E	P/B	EV/EBIT	Free-cash-flow yield	Dividend yield	Smart Score
LLYEli Lilly & Co	42,6	33,6	—	%1,6	%0,6	6/10
JNJJohnson & Johnson	29,1	7,2	—	%3,6	%2,1	8/10
ABBVAbbVie	79,9	—	33,5	%3,6	%3,0	5/10
MRKMerck	114,6	8,7	—	%4,4	%2,3	8/10
UNHUnitedHealth	25,1	3,4	18,6	%6,7	%2,3	9/10
TMOThermo Fisher Scientific	35,7	4,7	35,2	%2,9	%0,3	8/10
AMGNAmgen	26,3	19,7	24,0	%4,4	%2,3	6/10
GILDGILEAD	—	16,1	—	%6,8	%2,1	4/10
ABTAbbott	28,5	3,4	26,8	%4,1	%3,0	5/10
PFEPfizer	38,4	2,0	—	%6,6	%5,9	1/10

Fiscal-year history

From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.

Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 30 Haz 2026 · filed 05 Ağu 2026

Buradan sözleşmeden çıkın · AB tüketicileri: Bir satın alma işlemini iptal etmek için 14 gün.